Paclitaxel hyperthermia suppresses gastric cancer migration through MiR-183-5p/PPP2CA/AKT/GSK3β/β-catenin axis

Xiansheng Yang,Chang Liu,Zheng Li,Juncai Wen,Jinfu He,Yunxin Lu,Quanxing Liao,Tian Wang,Hongsheng Tang,Xianzi Yang,Lisi Zeng
DOI: https://doi.org/10.1007/s00432-024-05923-y
2024-09-11
Journal of Cancer Research and Clinical Oncology
Abstract:Gastric cancer (GC), a prevalent malignant tumor which is a leading cause of death from malignancy around the world. Peritoneal metastasis accounts for the major cause of mortality in patients with GC. Despite hyperthermia intraperitoneal chemotherapy (HIPEC) improves the therapeutic effect of GC, it's equivocal about the mechanism under HIPEC.
oncology
What problem does this paper attempt to address?